Generate Biomedicines IPO

generatebiomedicines.com

Generate Biomedicines uses machine learning and biological engineering to create innovative medicines.

Founded2018
Total Funding to Date$410.25MM
Register for Details

For more details on financing and valuation for Generate Biomedicines, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Generate Biomedicines Ticker Symbol

Generate Biomedicines does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Generate Biomedicines Stock Price

The stock price for Generate Biomedicines will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Generate Biomedicines Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
11/18/2021 Series B $1.52B $XXX.XX $XXX.XX
9/10/2020 Series A $89.44MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Generate Biomedicines in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM